ATORVASTATIN CALCIUM

Product NDC: 59762-0156
11-digit product format: 597620156
Labeler code: 59762
Product ID: 59762-0156_77ffa111-a87b-4108-ba93-7fe639456515
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: ATORVASTATIN CALCIUM
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Greenstone LLC
Application: NDA020702
Marketing category: NDA AUTHORIZED GENERIC
Marketing start: 2013-01-28
Marketing end: 0000-00-00
Substance: ATORVASTATIN CALCIUM TRIHYDRATE
Active strength: 20 mg/1
Pharmacologic classes: HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	59762-0156		D	Discontinued by firm	2026-08-11
excluded package	package	59762-0156	59762-0156-1	D	Discontinued by firm	2026-08-11
excluded package	package	59762-0156	59762-0156-2	D	Discontinued by firm	2026-08-11

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 36 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59762-0156-2	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	59762-0156-1	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59762-0156-2	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	59762-0156-1	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59762-0156-2	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	59762-0156-1	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59762-0156-2	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	59762-0156-1	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59762-0156-2	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	59762-0156-1	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59762-0156-2	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	59762-0156-1	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59762-0156-2	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	59762-0156-1	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59762-0156-2	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	59762-0156-1	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59762-0156-2	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	59762-0156-1	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59762-0156-2	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	59762-0156-1	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59762-0156-2	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	59762-0156-1	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59762-0156-2	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	59762-0156-1	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020702-001	LIPITOR	ATORVASTATIN CALCIUM	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17
N020702-002	LIPITOR	ATORVASTATIN CALCIUM	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17
N020702-003	LIPITOR	ATORVASTATIN CALCIUM	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17
N020702-004	LIPITOR	ATORVASTATIN CALCIUM	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
N020702-001	AB
N020702-002	AB
N020702-003	AB
N020702-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020702-001	LIPITOR	EQ 10MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020702-002	LIPITOR	EQ 20MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020702-003	LIPITOR	EQ 40MG BASE	TABLET / ORAL	AB	RLD	1996-12-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020702-004	LIPITOR	EQ 80MG BASE	TABLET / ORAL	AB	RLD, RS	2000-04-07	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N020702-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020702-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020702-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020702-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020702-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020702-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020702-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020702-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020702-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020702-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020702-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020702-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020702-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020702-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020702-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020702-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020702-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020702-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020702-004	AB	1	`d06236e962d9…`

Observed Orange Book exclusivity history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	Exclusivity code	Expiration	Source SHA-256
2019-12-13 00:20 UTC	2019-12	N020702-001	M-204	2020-06-23	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	N020702-002	M-204	2020-06-23	`74a2ff9319b5…`
2020-12-22 03:56 UTC	2020-12	N020702-001	M-204	2020-06-23	`8869cabd3fbd…`
2020-12-22 03:56 UTC	2020-12	N020702-002	M-204	2020-06-23	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	N020702-001	M-204	2020-06-23	`c0c555d07b60…`
2020-11-12 02:37 UTC	2020-11	N020702-002	M-204	2020-06-23	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	N020702-001	M-204	2020-06-23	`3f01610625f2…`
2019-12-14 00:12 UTC	2019-12	N020702-002	M-204	2020-06-23	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	N020702-001	M-204	2020-06-23	`b00525d2431f…`
2019-09-15 20:21 UTC	2019-09	N020702-002	M-204	2020-06-23	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	N020702-001	M-204	2020-06-23	`ea99ee380514…`
2019-07-19 19:46 UTC	2019-07	N020702-002	M-204	2020-06-23	`ea99ee380514…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
fa898d56-9495-d6f0-309b-68a5d8e3914a	Product name	4	20260305
d25cba4b-d79e-4890-8837-1382f7d09489	Product name	1	20231002
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
91774e91-b249-45e3-8ff8-4b5db2927a69	Product name	1	20230718
03fb3cda-d60a-4873-94e9-6fa77cfb1a1c	Product name	1	20220302
34152997-af0b-acf4-dcaf-37211afe8ca4	Product name	9	20210312
46fdf265-6d5a-1bfb-93db-d82a4ea8aa81	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
59762-0156-1	EA - Each	59762-0156	6231f656-3393-4e96-b532-34d9b41e01e5	1	2013-02-13
59762-0156-2	EA - Each	59762-0156	e23c6015-d450-43b0-b466-bf39f46604da	1	2013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [GREENSTONE LLC]	3
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING, LLC]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [STATE OF FLORIDA DOH CENTRAL PHARMACY]	2
ATORVASTATIN CALCIUM	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
ATORVASTATIN CALCIUM TRIHYDRATE	ACTIVE INGREDIENT	48A5M73Z4Q	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
ATORVASTATIN	ACTIVE MOIETY	A0JWA85V8F	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
CALCIUM CARBONATE	INACTIVE INGREDIENT	H0G9379FGK	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
CROSCARMELLOSE SODIUM	INACTIVE INGREDIENT	M28OL1HH48	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
HYDROXYPROPYL CELLULOSE (TYPE H)	INACTIVE INGREDIENT	RFW2ET671P	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
POLYSORBATE 80	INACTIVE INGREDIENT	6OZP39ZG8H	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [LEGACY PHARMACEUTICAL PACKAGING]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ATORVASTATIN CALCIUM TABLET, FILM COATED [KAISER FOUNDATION HOSPITALS]	1

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lipitor	ATORVASTATIN CALCIUM	Viatris Specialty LLC	a60cc18b-0631-4cf0-b021-9f52224ece65	2024-04-15	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020702 application number: NDA020702

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
48A5M73Z4Q	ATORVASTATIN CALCIUM TRIHYDRATE	344423-98-9	ATORVASTATIN CALCIUM TRIHYDRATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
617310	atorvastatin calcium 20 MG Oral Tablet	PSN	1b1faadc-b8b5-4545-a12b-060a90881aec	4
617311	atorvastatin calcium 40 MG Oral Tablet	PSN	1b1faadc-b8b5-4545-a12b-060a90881aec	4
259255	atorvastatin calcium 80 MG Oral Tablet	PSN	1b1faadc-b8b5-4545-a12b-060a90881aec	4
617310	atorvastatin 20 MG Oral Tablet	SCD	1b1faadc-b8b5-4545-a12b-060a90881aec	4
617311	atorvastatin 40 MG Oral Tablet	SCD	1b1faadc-b8b5-4545-a12b-060a90881aec	4
259255	atorvastatin 80 MG Oral Tablet	SCD	1b1faadc-b8b5-4545-a12b-060a90881aec	4
617310	atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet	SY	1b1faadc-b8b5-4545-a12b-060a90881aec	4
617311	atorvastatin (as atorvastatin calcium) 40 MG Oral Tablet	SY	1b1faadc-b8b5-4545-a12b-060a90881aec	4
259255	atorvastatin (as atorvastatin calcium) 80 MG Oral Tablet	SY	1b1faadc-b8b5-4545-a12b-060a90881aec	4
617310	atorvastatin calcium 20 MG Oral Tablet	PSN	cc710d44-d515-4b17-a3c6-4d3ba9b049f8	2
617310	atorvastatin 20 MG Oral Tablet	SCD	cc710d44-d515-4b17-a3c6-4d3ba9b049f8	2
617310	atorvastatin (as atorvastatin calcium) 20 MG Oral Tablet	SY	cc710d44-d515-4b17-a3c6-4d3ba9b049f8	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
59762-0156-1	59762015601	90 TABLET, FILM COATED in 1 BOTTLE (59762-0156-1)	2013-01-28	0000-00-00	No	No	Current
59762-0156-2	59762015602	1000 TABLET, FILM COATED in 1 BOTTLE (59762-0156-2)	2013-01-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ATORVASTATIN CALCIUM	REMEDYREPACK INC.	2022-01-07	HUMAN PRESCRIPTION DRUG LABEL	1
ATORVASTATIN CALCIUM	Greenstone LLC \| Pfizer Inc \| Viatris Pharmaceuticals LLC \| Pfizer Ireland Pharmaceuticals \| Upjohn Manufacturing Ireland Unlimited Company \| Pfizer Asia Manufacturing Pte Ltd \| Pfizer Manufacturing Deutschland GmbH	2020-12-10	HUMAN PRESCRIPTION DRUG LABEL	16
ATORVASTATIN CALCIUM	Bryant Ranch Prepack	2020-10-16	HUMAN PRESCRIPTION DRUG LABEL	8
ATORVASTATIN CALCIUM	Legacy Pharmaceutical Packaging, LLC	2020-02-13	HUMAN PRESCRIPTION DRUG LABEL	11
ATORVASTATIN CALCIUM	Aphena Pharma Solutions - Tennessee, LLC	2019-12-20	HUMAN PRESCRIPTION DRUG LABEL	4
ATORVASTATIN CALCIUM	Legacy Pharmaceutical Packaging, LLC	2019-01-15	HUMAN PRESCRIPTION DRUG LABEL	6
ATORVASTATIN CALCIUM	KAISER FOUNDATION HOSPITALS	2018-11-26	HUMAN PRESCRIPTION DRUG LABEL	4
ATORVASTATIN CALCIUM	State of Florida DOH Central Pharmacy	2014-10-08	HUMAN PRESCRIPTION DRUG LABEL	2